Literature DB >> 25132506

Chikungunya virus control: is a vaccine on the horizon?

Ann M Powers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25132506      PMCID： PMC6443378          DOI： 10.1016/S0140-6736(14)61290-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  How the research-based industry approaches vaccine development and establishes priorities.

Authors:  F E André
Journal:  Dev Biol (Basel)       Date:  2002

2.  Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.

Authors:  R T Mahoney; D P Francis; N M Frazatti-Gallina; A R Precioso; I Raw; P Watler; P Whitehead; S S Whitehead
Journal:  Vaccine       Date:  2012-03-08       Impact factor: 3.641

3.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Authors:  R Edelman; C O Tacket; S S Wasserman; S A Bodison; J G Perry; J A Mangiafico
Journal:  Am J Trop Med Hyg       Date:  2000-06       Impact factor: 2.345

4.  A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection.

Authors:  Wataru Akahata; Zhi-Yong Yang; Hanne Andersen; Siyang Sun; Heather A Holdaway; Wing-Pui Kong; Mark G Lewis; Stephen Higgs; Michael G Rossmann; Srinivas Rao; Gary J Nabel
Journal:  Nat Med       Date:  2010-01-28       Impact factor: 53.440

5.  Unforeseen costs of cutting mosquito surveillance budgets.

Authors:  Gonzalo M Vazquez-Prokopec; Luis F Chaves; Scott A Ritchie; Joe Davis; Uriel Kitron
Journal:  PLoS Negl Trop Dis       Date:  2010-10-26

6.  Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005.

Authors:  Kibet Sergon; Ali Ahmed Yahaya; Jennifer Brown; Said A Bedja; Mohammed Mlindasse; Naphtali Agata; Yokouide Allaranger; Mamadou D Ball; Ann M Powers; Victor Ofula; Clayton Onyango; Limbaso S Konongoi; Rosemary Sang; M Kariuki Njenga; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

7.  US Military contributions to the global response to pandemic chikungunya.

Authors:  Charles H Hoke; Judy Pace-Templeton; Phillip Pittman; Frank J Malinoski; Paul Gibbs; Tracy Ulderich; Michelle Mathers; Beverly Fogtman; Pamela Glass; David W Vaughn
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

8.  Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.

Authors:  Don L Douglas; Denise A DeRoeck; Richard T Mahoney; Ole Wichmann
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

9.  The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study.

Authors:  Man-Koumba Soumahoro; Pierre-Yves Boelle; Bernard-Alex Gaüzere; Kokuvi Atsou; Camille Pelat; Bruno Lambert; Guy La Ruche; Marc Gastellu-Etchegorry; Philippe Renault; Marianne Sarazin; Yazdan Yazdanpanah; Antoine Flahault; Denis Malvy; Thomas Hanslik
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14

10.  Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic.

Authors:  Patrick Gérardin; Vanina Guernier; Joëlle Perrau; Adrian Fianu; Karin Le Roux; Philippe Grivard; Alain Michault; Xavier de Lamballerie; Antoine Flahault; François Favier
Journal:  BMC Infect Dis       Date:  2008-07-28       Impact factor: 3.090
View more
  11 in total

Review 1.  Do we need a vaccine against chikungunya?

Authors:  Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2015-05-14       Impact factor: 2.894

2.  Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.

Authors:  Pierre Roques; Karl Ljungberg; Beate M Kümmerer; Leslie Gosse; Nathalie Dereuddre-Bosquet; Nicolas Tchitchek; David Hallengärd; Juan García-Arriaza; Andreas Meinke; Mariano Esteban; Andres Merits; Roger Le Grand; Peter Liljeström
Journal:  JCI Insight       Date:  2017-03-23

Review 3.  That Which Bends Up: A Case Report and Literature Review of Chikungunya Virus.

Authors:  Shana M Peper; Benjamin J Monson; Trevor Van Schooneveld; Christopher J Smith
Journal:  J Gen Intern Med       Date:  2015-07-21       Impact factor: 5.128

4.  Diagnostic challenges in chikungunya infection: Report of an atypical presentation.

Authors:  J Craig; M Klowak; A K Boggild
Journal:  Can Commun Dis Rep       Date:  2015-01-08

5.  The global compendium of Aedes aegypti and Ae. albopictus occurrence.

Authors:  Moritz U G Kraemer; Marianne E Sinka; Kirsten A Duda; Adrian Mylne; Freya M Shearer; Oliver J Brady; Jane P Messina; Christopher M Barker; Chester G Moore; Roberta G Carvalho; Giovanini E Coelho; Wim Van Bortel; Guy Hendrickx; Francis Schaffner; G R William Wint; Iqbal R F Elyazar; Hwa-Jen Teng; Simon I Hay
Journal:  Sci Data       Date:  2015-07-07       Impact factor: 6.444

6.  Vaccines, emerging viruses, and how to avoid disaster.

Authors:  Rino Rappuoli
Journal:  BMC Biol       Date:  2014-11-29       Impact factor: 7.431

7.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus.

Authors:  Moritz U G Kraemer; Marianne E Sinka; Kirsten A Duda; Adrian Q N Mylne; Freya M Shearer; Christopher M Barker; Chester G Moore; Roberta G Carvalho; Giovanini E Coelho; Wim Van Bortel; Guy Hendrickx; Francis Schaffner; Iqbal R F Elyazar; Hwa-Jen Teng; Oliver J Brady; Jane P Messina; David M Pigott; Thomas W Scott; David L Smith; G R William Wint; Nick Golding; Simon I Hay
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

Review 8.  Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development.

Authors:  Giovanni Rezza; Scott C Weaver
Journal:  PLoS Negl Trop Dis       Date:  2019-01-17

9.  Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus.

Authors:  Jelke J Fros; Corinne Geertsema; Karima Zouache; Jim Baggen; Natalia Domeradzka; Daniël M van Leeuwen; Jacky Flipse; Just M Vlak; Anna-Bella Failloux; Gorben P Pijlman
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

10.  Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.

Authors:  Heidi Auerswald; Camille Boussioux; Saraden In; Sokthearom Mao; Sivuth Ong; Rekol Huy; Rithea Leang; Malen Chan; Veasna Duong; Sowath Ly; Arnaud Tarantola; Philippe Dussart
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.